Compositions comprising secretory IgA and probiotics
US-12350332-B2 · Jul 8, 2025 · US
US9475860B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9475860-B2 |
| Application number | US-201414168586-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 30, 2014 |
| Priority date | Jan 31, 2013 |
| Publication date | Oct 25, 2016 |
| Grant date | Oct 25, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Suggested is a process for obtaining immunoglobulins, wherein (a) colostral milk from days 0 to 7 is subjected to thermal treatment, skimming the cream, (b) the skimmed milk such obtained is subjected to sterile microfiltration thus producing a first retentate R 1 which contains the casein, and a first permeate P 1 , (c) the first permeate P 1 is subjected to ultrafiltration thus producing a second permeate P2 which contains lactose and minerals, and a second retentate R 2 , in which the immunoglobulins are concentrated.
Opening claim text (preview).
The invention claimed is: 1. A process for obtaining immunoglobulins consisting essentially of: (a) colostral milk from days 0to 7is subjected to thermal treatment, skimming the cream, (b) the skimmed milk such obtained is subjected at a temperature of from about 50 to about 70° C. to a sterile microfiltration thus producing a first retentate R 1 which contains the casein, and a first permeate P 1 , (c) the first permeate P 1 is subjected at a temperature of from about 5 to about 15° C. to ultrafiltration thus producing a second permeate P 2 which contains lactose and minerals, and a second retentate R 2 , in which the immunoglobulins are concentrated, and (d) the immunoglobulins thus obtained from the second retentate are separated off from by treatment with anion exchanger. 2. The process of claim 1 wherein the colostral milk is treated at a temperature of from about 70 to about 80° C. 3. The process of claim 1 , wherein the colostral milk is treated for a period from about 10 to about 30 s. 4. The process of claim 1 , wherein microfiltration is performed using membranes having a selective separation of from about 0.1 to about 0.2 μm. 5. The process of claim 1 , wherein microfiltration is performed by means of a ceramic membrane. 6. The process of claim 1 , wherein ultrafiltration is performed using membranes having a selective separation of from about 0.01 to about 0.1 μm. 7. The process of claim 1 , wherein ultrafiltration is performed by means of a spiral coil membrane. 8. The process of claim 1 , wherein separation is performed by means of an anion exchanger at a temperature within the range of from about 2 to about 25° C. 9. The process of claim 1 , wherein separation is performed by means of an anion exchanger at a pH value of from about 6 to about 7.
Dairy proteins · CPC title
by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate · CPC title
from milk · CPC title
Colostrum; Human milk · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.